Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 3Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 6Sarcoma 3Gynecologic 2Other solid neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Sarcoma 2Sarcoma, Ewing 1Osteosarcoma 1

Interventions

Doxorubicin 25Cyclophosphamide 24pembrolizumab 20Specimen Handling 19Temozolomide 16Magnetic Resonance Spectroscopy 15Surgical Procedures, Operative 14Radiotherapy 13Blood Specimen Collection 13Biopsy 13atezolizumab 12Gemcitabine 12fludarabine 11Vincristine 11Ifosfamide 11X-Rays 8Trabectedin 8Nivolumab 8Irinotecan 8Imatinib Mesylate 8Drug Therapy 8cabozantinib 7Surveys and Questionnaires 7Radiation 7liposomal doxorubicin 5abemaciclib 5Sunitinib 5Standard of Care 5Radiation Dose Hypofractionation 5Dactinomycin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × fluzoparib × Sarcoma × Clear all
NCT06827717 2025-05-31

Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma

Sun Yat-sen University

Phase 2 Recruiting
29 enrolled
Sarcoma

Sarcoma, Ewing

NCT05894018 2025-05-13

RAFAS-001

Sun Yat-sen University

Phase 2 Recruiting
32 enrolled
Sarcoma

Sarcoma

NCT06074692 2023-10-31

PRIMA

Ruijin Hospital

Phase 2 Recruiting
86 enrolled
Sarcoma

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡